Literature DB >> 26032381

Neurocognitive performance and prior injury among U.S. Department of Defense military personnel.

Susan P Proctor1, Kenneth Nieto1, Kristin J Heaton1, Caitlin C Dillon1, Robert E Schlegel2, Michael L Russell2, Andrea S Vincent3.   

Abstract

This study examined the neurocognitive performance of U.S. military personnel completing the Automated Neuropsychological Assessment Metrics (version 4) TBI Military (ANAM4 TBI-MIL) battery as part of the Department of Defense Neurocognitive Functional Assessment Program. Descriptive analyses utilizing the ANAM4TBI Military Performance Database were performed. We examined ANAM Composite Score (ACS) differences between five injury subgroups (no injury, brain injury with current symptoms, brain injury without current symptoms, nonbrain injury with current symptoms, and nonbrain injury without current symptoms) using general linear mixed modeling. Almost 11% (70,472/641,285) reported brain injury in the 4 years before assessment. The ACS differed significantly by injury group (p < 0.0001). In comparison to the no injury group, those reporting brain injury with current symptoms (d = -0.44) and nonbrain injury with current symptoms (d = -0.24) demonstrated significantly reduced ACS scores (p < 0.0001) indicative of reduced neurocognitive proficiency. In this population-based study of U.S. military personnel, neurocognitive performance was significantly associated with reported injury within the past 4 years among those experiencing current symptoms. Occupational programs focusing on prospective brain health of injured population groups are warranted. Reprint &
Copyright © 2015 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Year:  2015        PMID: 26032381     DOI: 10.7205/MILMED-D-14-00298

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  1 in total

1.  Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus.

Authors:  Kimberley Yuen; Dorcas Beaton; Kathleen Bingham; Patricia Katz; Jiandong Su; Juan Pablo Diaz Martinez; Maria Carmela Tartaglia; Lesley Ruttan; Joan E Wither; Mahta Kakvan; Nicole Anderson; Dennisse Bonilla; May Y Choi; Marvin J Fritzler; Robin Green; Zahi Touma
Journal:  Lupus       Date:  2021-12-27       Impact factor: 2.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.